Medicare Part D coverage · indomethacin · RxCUI 310991

indomethacin 5 MG/ML Oral Suspension

Per the CMS 2026 Part D formulary file, indomethacin 5 MG/ML Oral Suspension is covered by 11 Medicare Part D plans (0.2% of enrollable products), averaging Tier 2.5, with prior authorization required on 0% of covering formularies.

0.2%
Plan coverage
11
Plans covering
T2.5
Avg tier
0%
Prior auth required

Verify with CMS →

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.

What the CMS Formulary Data Shows for indomethacin 5 MG/ML Oral Suspension

Per the CMS 2026 Part D formulary file, indomethacin 5 MG/ML Oral Suspension (RxNorm concept RXCUI 310991, generic name indomethacin) appears on 2 distinct formulary files spanning 11 Medicare Part D plan offerings - 0.2% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.5.

Real-world access to indomethacin 5 MG/ML Oral Suspension depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 123,532 Part D beneficiaries filled indomethacin 5 MG/ML Oral Suspension in 2023, with total plan-and-beneficiary spending of $3,235,993 and an average per-beneficiary annual cost of $26.20. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry indomethacin 5 MG/ML Oral Suspension today.

Coverage Details

Formularies covering
2
Plans covering
11
Coverage rate
0.2%
Tier range
Tier 1 – Tier 4
Average tier
Tier 3, Preferred Brand

Restrictions

Prior authorization required
0% of formularies
Step therapy required
0% of formularies
Quantity limits
0% of formularies

2023 Medicare Spending

Beneficiaries
123,532
Total spending
$3,235,993
Avg per beneficiary
$26.20

Tier Distribution Across Plans

1 plans
Tier 1, Preferred Generic
10 plans
Tier 4, Non-Preferred

Standalone Drug Plans (PDP) Covering indomethacin 5 MG/ML Oral Suspension

2 standalone prescription drug plans include this drug.

Plan Insurer Tier PA ST Premium States
Blue Rx PDP Complete (PDP) HM Health Insurance Company T4 No No $164.80 -
Blue Rx PDP Plus (PDP) HM Health Insurance Company T4 No No $193.20 -

Medicare Advantage Plans (MA-PD) Covering indomethacin 5 MG/ML Oral Suspension

9 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
CareAdvantage (HMO D-SNP) SAN Mateo Health Commission T1 No $0 CA
Security Blue HMO-POS Standard (HMO-POS) Highmark Choice Company T4 No $51.80 PA
Freedom Blue PPO Select (PPO) Highmark Senior Health Company T4 No $95.70 PA
Security Blue HMO-POS Deluxe (HMO-POS) Highmark Choice Company T4 No $95.90 PA
Freedom Blue PPO Standard (PPO) Highmark Senior Health Company T4 No $98.20 PA
Freedom Blue PPO Select (PPO) Highmark Senior Health Company T4 No $115.70 PA
Freedom Blue PPO Deluxe (PPO) Highmark Senior Health Company T4 No $122.40 PA
Freedom Blue PPO Classic (PPO) Highmark Senior Health Company T4 No $140.90 PA
Freedom Blue PPO Classic (PPO) Highmark Senior Health Company T4 No $145.40 PA

Frequently Asked Questions

Is indomethacin 5 MG/ML Oral Suspension covered by Medicare Part D?

Yes, indomethacin 5 MG/ML Oral Suspension is covered by 11 Medicare Part D plans (0.2% of all Part D formularies).

What tier is indomethacin 5 MG/ML Oral Suspension on Medicare Part D plans?

indomethacin 5 MG/ML Oral Suspension averages Tier 2.5 across Part D plans, ranging from Tier 1 to Tier 4.

Does indomethacin 5 MG/ML Oral Suspension require prior authorization?

0% of Part D formularies require prior authorization for indomethacin 5 MG/ML Oral Suspension. Step therapy: 0%. Quantity limits: 0%.

How much does Medicare spend on indomethacin 5 MG/ML Oral Suspension?

In 2023, total Medicare Part D spending on indomethacin 5 MG/ML Oral Suspension was $3,235,993, covering 123,532 beneficiaries. The average spend per beneficiary was $26.20.

Read our methodology - how this data is sourced, computed, and verified.

Nationwide similar Part D drugs

Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.

Closest average formulary tier

Similar prior-authorization rate

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare